Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Influenza Nucleoprotein Products

(Influenza Nucleoprotein (NP))
Encapsidates the negative strand viral RNA, protecting it from nucleases. The encapsidated genomic RNA is termed the ribonucleoprotein (RNP) and serves as template for transcription and replication. The RNP needs to be localized in the nucleus to start an infectious cycle, but is too large to diffuse through the nuclear pore complex. NP comprises at least 2 nuclear localization signals and is responsible of the active RNP import into the nucleus through the cellular importin alpha/beta pathway. Later in the infection, nucleus export of RNP are mediated through viral proteins NEP interacting with M1 which binds nucleoproteins. It is possible that the nucleoprotein binds directly exportin-1 (XPO1) and plays an active role in RNP nuclear export. M1 interaction with RNP seems to hide nucleoprotein's nuclear localization signals. Soon after a virion infects a new cell, M1 dissociates from the RNP under acidification of the virion driven by M2 protein. Dissociation of M1 from RNP unmask nucleoprotein's nuclear localization signals, targeting the RNP to the nucleus (By similarity).

antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.

Featured Influenza Nucleoprotein Categories

Influenza Nucleoprotein Antibodies

High quality antibodies with extensive validation data.

Influenza Nucleoprotein Proteins

Proteins for various applications incl. WB, ELISA, IF etc.

Recommended Influenza Nucleoprotein Antibodies

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Influenza A Virus H2N2
Application ELISA, WB, IF, IHC, IP, IC
Validations
  • (3)
  • (4)
Cat. No. ABIN2452039
Quantity 100 μg
Datasheet Datasheet
Reactivity Influenza A Virus H2N2
Application ELISA, WB, IHC, IC
Validations
  • (3)
  • (3)
Cat. No. ABIN2452038
Quantity 50 μg
Datasheet Datasheet
Reactivity Influenza B Virus
Application ELISA
Validations
  • (1)
  • (1)
Cat. No. ABIN5707182
Quantity 1 mL
Datasheet Datasheet

Recommended Influenza Nucleoprotein Proteins

Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity Influenza B Virus
Source HEK-293 Cells
Validations
Cat. No. ABIN7385956
Quantity 1 mg
Datasheet Datasheet
Reactivity Influenza A Virus
Source HEK-293 Cells
Validations
Cat. No. ABIN7385954
Quantity 1 mg
Datasheet Datasheet
Reactivity Influenza A Virus
Source Escherichia coli (E. coli)
Validations
Cat. No. ABIN7519580
Quantity 1 mg
Datasheet Datasheet

Latest Publications for our Influenza Nucleoprotein products

Hao, Wang, Li: "FKBP5 Regulates RIG-I-Mediated NF-κB Activation and Influenza A Virus Infection." in: Viruses, Vol. 12, Issue 6, (2020) (PubMed).

Hong, Song, Kim, Cho, Jeong, Yang, Jeong, Ahn, Jeong, Kim, Chang, Ko: "Morin Hydrate Inhibits Influenza Virus entry into Host Cells and Has Anti-inflammatory Effect in Influenza-infected Mice." in: Immune network, Vol. 20, Issue 4, pp. e32, (2020) (PubMed).

Gogoi, Mansouri, Katikaneni, Jin: "New MoDC-Targeting TNF Fusion Proteins Enhance Cyclic Di-GMP Vaccine Adjuvanticity in Middle-Aged and Aged Mice." in: Frontiers in immunology, Vol. 11, pp. 1674, (2020) (PubMed).

Mansouri, Katikaneni, Gogoi, Pipkin, Machuca, Emtiazjoo, Jin: "Lung IFNAR1hi TNFR2+ cDC2 promotes lung regulatory T cells induction and maintains lung mucosal tolerance at steady state." in: Mucosal immunology, Vol. 13, Issue 4, pp. 595-608, (2020) (PubMed).

Tan, Esterbauer, Vanderven, Juno, Kent, Wheatley: "Inducible Bronchus-Associated Lymphoid Tissues (iBALT) Serve as Sites of B Cell Selection and Maturation Following Influenza Infection in Mice." in: Frontiers in immunology, Vol. 10, pp. 611, (2020) (PubMed).

Zhao, Sridharan, Chen, Baker, Wang, Krug: "Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins." in: Nature communications, Vol. 7, pp. 12754, (2018) (PubMed).

Kamal, Blanchfield, Belser, Music, Tzeng, Holiday, Burroughs, Sun, Maines, Levine, York: "Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies." in: Journal of virology, Vol. 91, Issue 20, (2017) (PubMed).

Bose, McCaul, Mei, Sasman, He, Kramp, Shively, Yan, Henrickson: "Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays." in: PLoS ONE, Vol. 11, Issue 11, pp. e0166800, (2017) (PubMed).

Belardo, Cenciarelli, La Frazia, Rossignol, Santoro: "Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro." in: Antimicrobial agents and chemotherapy, Vol. 59, Issue 2, pp. 1061-9, (2015) (PubMed).

Kim, Kim, Lee, Chu, Kang, Kim, Lee: "Pathogenesis of novel reassortant avian influenza virus A (H5N8) Isolates in the ferret." in: Virology, Vol. 481, pp. 136-41, (2015) (PubMed).

Synonyms and alternative names related to Influenza Nucleoprotein

nucleoprotein (NP)
You are here:
Support